CHRM4 and prostate carcinoma: Moreover, tissues expressing high CHRM4 levels were significantly correlated with downregulated AR-responsive gene signatures (GO, Wang [13], Nelson [14], PID, and Hallmark), as revealed by a gene set enrichment analysis (GSEA) in The Cancer Genome Atlas (TCGA) prostate cancer dataset (Fig. 1H).